- Home
- BME vs AMLX Comparison
BME vs AMLX Comparison
Compare BME & AMLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BME
- AMLX
- Stock Information
- Founded
- BME 2005
- AMLX 2014
- Country
- BME United States
- AMLX United States
- Employees
- BME N/A
- AMLX N/A
- Industry
- BME Trusts Except Educational Religious and Charitable
- AMLX Biotechnology: Pharmaceutical Preparations
- Sector
- BME Finance
- AMLX Health Care
- Exchange
- BME Nasdaq
- AMLX Nasdaq
- Market Cap
- BME 462.3M
- AMLX 459.1M
- IPO Year
- BME N/A
- AMLX 2022
- Fundamental
- Price
- BME $36.35
- AMLX $6.35
- Analyst Decision
- BME
- AMLX Strong Buy
- Analyst Count
- BME 0
- AMLX 7
- Target Price
- BME N/A
- AMLX $11.14
- AVG Volume (30 Days)
- BME 34.0K
- AMLX 1.7M
- Earning Date
- BME 01-01-0001
- AMLX 08-07-2025
- Dividend Yield
- BME 6.26%
- AMLX N/A
- EPS Growth
- BME N/A
- AMLX N/A
- EPS
- BME 1.44
- AMLX N/A
- Revenue
- BME N/A
- AMLX N/A
- Revenue This Year
- BME N/A
- AMLX N/A
- Revenue Next Year
- BME N/A
- AMLX N/A
- P/E Ratio
- BME $28.37
- AMLX N/A
- Revenue Growth
- BME N/A
- AMLX N/A
- 52 Week Low
- BME $35.53
- AMLX $1.62
- 52 Week High
- BME $43.20
- AMLX $7.27
- Technical
- Relative Strength Index (RSI)
- BME 55.94
- AMLX 64.97
- Support Level
- BME $35.30
- AMLX $6.08
- Resistance Level
- BME $36.49
- AMLX $6.59
- Average True Range (ATR)
- BME 0.37
- AMLX 0.43
- MACD
- BME 0.05
- AMLX 0.10
- Stochastic Oscillator
- BME 82.27
- AMLX 81.05
About BME Blackrock Health Sciences Trust
Blackrock Health Sciences Trust has an investment objective to provide total return through a combination of current income, current gains, and long-term capital appreciation. The Fund invests 80% of its total assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives.
About AMLX Amylyx Pharmaceuticals Inc.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder and endocrine conditions.